102391-96-8 Usage
General Description
3-(4-Benzoylpiperazinyl)propanamine is a chemical compound that belongs to the class of piperazine derivatives. It is characterized by a benzoyl group attached to the piperazine ring, as well as a propanamine group. 3-(4-Benzoylpiperazinyl)propanamine has potential pharmacological activity and has been studied for its potential use as a psychoactive drug. The presence of the benzoyl and propanamine groups may contribute to its biological activity and may have implications for its potential use in medicine. However, further research is needed to fully understand its properties and potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 102391-96-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,3,9 and 1 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 102391-96:
(8*1)+(7*0)+(6*2)+(5*3)+(4*9)+(3*1)+(2*9)+(1*6)=98
98 % 10 = 8
So 102391-96-8 is a valid CAS Registry Number.
InChI:InChI=1/C14H21N3O/c15-7-4-8-16-9-11-17(12-10-16)14(18)13-5-2-1-3-6-13/h1-3,5-6H,4,7-12,15H2
102391-96-8Relevant articles and documents
Fused imidazopyridine derivatives as antihyperlipidemic agents
-
, (2008/06/13)
A novel compound of the formula: wherein ring Q is an optionally substituted pyridine ring; One of R0, R1and R2is —Y0—Z0, and the other tow groups are a hydrogen, a halogen, an optionally substituted hydroxy group, a hydrocarbon group that may be an optionally substituted hydrocarbon group or an acyl group; Y0is a bond or an optionally substituted bivalent hydrocarbon group; Z0is a basic group which may be bonded via oxygen, nitrogen, —CO—, —CS—, —SO2N(R3)— (where R3is hydrogen or an optionally substituted hydrocarbon group), or S(O)n(wherein n is to 0, 1 or 2); .........is a single bond or a double bond, or a salt thereof, which has an excellent LDL receptor up-regulating, blood-lipids lowering, blood-sugar lowering and diabetic complication-ameliorating activity.
